Telix Pharmaceuticals Secures License to Cancer Treatments in Germany

MT NewswiresNov 19 08:54

Telix to Add FAP-Targeting Candidates to Theranostic Pipeline

PR NewswireNov 19 06:24

UBS Initiates Coverage On Telix Pharmaceuticals With Buy Rating, Announces Price Target of $21

BenzingaNov 15 20:26 · Ratings

Telix Pharmaceuticals Analyst Ratings

BenzingaNov 15 20:22 · Ratings

Telix ADSs Commence Trading on Nasdaq

GlobeNewswireNov 14 05:28

Subtle Medical Unveils Subtle-ELITE and New Strategic Partnerships at RSNA 2024

PR NewswireNov 13 20:50